SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending as community members discuss a recent price dip possibly connected to news of Amazon offering free trials of its DSP, raising concerns about increased competition. Some investors are calling for the CEO to address investor fears, while others speculate about market manipulation and the potential for a pre-earnings rally. The stock's volatile price action and sensitivity to broader market trends remain a key point of discussion.

Creative Media & Community Trust Corp. is a real estate investment trust that seeks to own, operate, and develop premier multifamily and creative office assets in vibrant and emerging communities throughout the United States. It operates through the following segments: Office, Hotel, and Lending. The Office segment consists of the rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The Hotel segment involves the operation of hotel properties. The Lending segment focuses on loans to small businesses. The company was founded in 1993 and is headquartered in Dallas, TX.

Creative Media & Community Trust

CMCT is trending as traders discuss a potential short squeeze and a low float, with some drawing comparisons to other stocks that have experienced significant upward movement. The community is actively watching key breakout levels, anticipating a rapid price increase if certain thresholds are met. However, concerns remain around reverse splits and the company's financials.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending due to FDA approval of its leukemia drug Revuforj, although a black box warning about potentially fatal side effects has tempered enthusiasm. The community is debating the significance of the safety label, with some seeing a buying opportunity while others express concern. Despite the approval, the stock has declined, prompting discussion about short selling, market manipulation, and potential future buyout offers.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

PMI is trending with increased after-hours activity, sparking speculation about its next move. While some community members point to a bull flag pattern and potential for further gains, others express concerns about a possible dilution and question the sustainability of the after-hours surge, leading to mixed sentiment and active discussion around its valuation.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels ($UUUU) is mega trending as traders discuss potential government contracts and insider trading activity based on recent call option sweeps. Community members are actively debating whether the stock will break through the $23 resistance and make a run to $27. The focus remains on domestic rare earth production and the potential impact of geopolitical events.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending due to discussions around its low float and potential for a significant short squeeze, with some drawing comparisons to other Hong Kong stocks that have experienced massive gains. Community members are debating its potential, citing its small float and upcoming news catalysts while also acknowledging concerns about dilution and large sellers. The stock's connection to the Hong Kong/China market and its potential for volatility are also driving interest.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending as retail investors rally behind a potential short squeeze, fueled by high borrowing costs and a perceived scarcity of shares available for shorting. The community is actively discussing strategies to pressure short sellers, with some pointing to insider buying as a bullish signal. Despite some volatility, there's a general sentiment that a significant move is on the horizon, and that high CTB/borrowing fees are making it hard for shorts to maintain positions.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase ($COIN) is trending as investors digest J.P. Morgan's upgrade to "overweight" and a raised price target, fueled by optimism around new revenue streams and the potential of its Base blockchain. Community members are actively discussing the stock's outperformance relative to Bitcoin YTD and anticipating a potential move towards new 52-week highs. Some traders are closely watching option activity, while others express concerns about correlation to crypto markets and volatility ahead of earnings.

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Neuphoria Therapeutics Inc.

NEUP is experiencing a surge, with community members pointing to insider buying and a milestone payment from Merck as potential catalysts. Discussions revolve around the stock's low float and the possibility of a short squeeze, leading to significant price movement. Some traders are exercising caution amid the excitement.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending amid discussions around its upcoming Kraken listing and speculation about future exchange listings. The community is weighing the potential impact of these listings on price action, with some expressing concerns about market manipulation and liquidity.  Also, discussions continue around Zebec's partnerships, utility, and overall potential within the crypto payment space, alongside debate about the project's credibility and long-term viability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hinge Health unveils new AI-powered care tools

Hinge Health, Inc. (NYSE:HNGE) today announced two AI-powered care tools: Movement Analysis uses computer vision to set a new standard for tracking musculoskeletal (MSK) outcomes, and Robin is an AI...

Hinge Health received widespread bullish initiation coverage on Monday from a dozen brokerages, with analysts highlighting its leadership in digital musculoskeletal (MSK) care, strong margins, and scalable AI platform.The stock ended 3.9% higher at $36.21 on Monday.Piper SandlerPiper Sandler started the stock at ‘Overweight’ with a $41 target, noting Hinge’s proprietary technology and sophisticated distribution strategy as drivers for sustained double-digit revenue growth.&nbsp;The firm pointed to a 2.4x or greater return on investment across commercial and Medicare populations, with durable 80%-plus gross margins and operating leverage as the company scales beyond its 2,250 clients and 20 million contracted lives as of Dec. 31, 2024.CanaccordCanaccord also began with a ‘Buy’ rating and a $52 target, describing Hinge as a “true innovator” disrupting traditional physical therapy through an AI-powered platform.&nbsp;The firm cited automation of 95% of care and emphasized the defensibility of Hinge’s position in the digital MSK market.BofABofA launched coverage with a ‘Buy’ rating and $42 target, calling Hinge the “digital physical therapy leader” with competitive advantages in its customer base, motion-tracking tech, and partnerships with five of the largest U.S. health plans.NeedhamNeedham began coverage with a ‘Buy’ rating and $47 target, calling Hinge the market leader in virtual MSK care and pointing to its advantages over digital competitors and legacy in-person providers.&nbsp;The firm noted that while 40% of Americans suffer from MSK issues, only 9% get treatment, creating a large untapped opportunity.William BlairWilliam Blair rated the stock ‘Outperform’ and described it as a core healthcare technology holding.&nbsp;The firm pointed to Hinge’s personalized digital app and supportive valuation at 5x 2026 revenue and 6.4x adjusted gross profit.Evercore ISIEvercore ISI also rated the stock ‘Outperform’ with a $50 target, citing broad employer and plan adoption and a multi-condition offering that supports continued 20% annual growth.TruistTruist gave it a ‘Buy’ rating and&nbsp;a $48 target, highlighting “enduring structural advantages,” strong outcomes data, and a flywheel driven by AI, partner networks, and attractive economics.StifelStifel started Hinge with a ‘Buy’ and $48 target, describing a platform that combines mobile app-based care with messaging and licensed PTs.&nbsp;The firm noted that Hinge became profitable and free cash flow positive in 2024, with room for further margin gains.RBC CapitalRBC Capital gave an ‘Outperform’ rating and&nbsp;a $45 target, saying the firm is well-positioned to scale digital MSK care across commercial, Medicare Advantage, and global markets, supported by strong validation and 20M covered lives.KeyBancKeyBanc began with an ‘Overweight’ and $45 target, describing Hinge as the clear leader in a large and underserved healthcare segment.&nbsp;The firm believes the recent 17% decline in share price post-IPO presents an attractive entry point.BarclaysBarclays also rated the stock ‘Overweight’ with a $43 target, saying Hinge can “bend the cost curve” in MSK with its tech and partnerships, and sees 15–20% billings growth translating into 20% revenue expansion.On Stocktwits, retail sentiment was ‘bearish’ amid ‘low’ message volume.The stock has declined 3.6% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Hinge Health logo is seen displayed on a smartphone and in the background. (Photo Illustration by Avishek Das/SOPA Images/LightRocket via Getty Images)

Wall Street Turns Bullish On Hinge Health As Analysts Laud Profitable Growth, AI Disruption In MSK Care

Analysts noted Hinge Health’s strong return on investment, rapid automation of care delivery, and profitability milestones as key drivers of their bullish stance.

Equity

Wall Street analysts start with bullish ratings on Hinge Health on growth potentia

Investing.com -- Shares of  Hinge Health  Inc (NYSE:HNGE) drew bullish coverage from several brokerages as analysts cited the company’s position as a leading provider of virtual physical therapy and highlighted its expanding market opportunity, improving margins, and adoption of artificial intelligence.

Virtual&nbsp;healthcare provider Omada Health&nbsp;(OMDA)&nbsp;priced its initial public offering (IPO) at $19 per share,&nbsp;at the midpoint of the previously estimated price range of $18 and $20 per share&nbsp;as per an amendment to the S-1 filing made in late May.The offering is expected to close on&nbsp;June 9.The San Francisco-based company&nbsp;would sell&nbsp;7.9 million shares of its common stock. Based on the IPO pricing, the company is set to raise gross proceeds of over $150 million.Additionally, Omada Health has given underwriters a 30-day option to buy up to 1.2 million&nbsp;additional&nbsp;shares of common stock at the IPO price, excluding underwriting discounts and commissions.At the IPO price, Omada is valued at around $1.1 billion, with the potential for a higher valuation on a fully diluted basis. It had raised $192 million in a Series E funding round led by Fidelity Management &amp; Research in February 2022.The shares are set to begin trading on the Nasdaq Global Select Market under the ticker symbol “OMDA” on June 6, 2025.Morgan Stanley, Goldman Sachs &amp; Co, and J.P. Morgan are serving as lead book-running managers for the offering. Barclays and Evercore ISI are acting as joint book-running managers, while Canaccord Genuity and Needham &amp; Company are serving as co-managers.Last month, digital physical therapy company Hinge Health&nbsp;debuted on the NYSE at $39.25 per share, 23% higher than its&nbsp;IPO price of $32. The shares have risen 20% since then.Omada provides virtual care programs designed to help patients manage chronic conditions such as prediabetes, diabetes, and hypertension. According to the prospectus, its revenue increased by 57% year-on-year to $55 million in the quarter ended March 31, 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, an IPO (Initial public offering) words are seen on a smartphone screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Omada Health Prices $150M IPO In-Line With Estimated Range

Omada Health (OMDA) priced its IPO at $19 per share, midpoint of the previously estimated price range of $18.00 and $20.00 per share

Omada Health (OMDA) priced its IPO at $19 per share, midpoint of the previously estimated price range of $18 and $20 per share

Shares of California-based Hinge Health, Inc. (HNGE) jumped 19% above its initial public offering price on Thursday in its debut on the New York Stock Exchange (NYSE).Shares of the company, which leverages software to automate care for joint and muscle health, opened at $39.2 before paring back some gains.<a href="https://stocktwits.com/symbol/HNGE">Hinge</a> said on Wednesday that the company and some of its selling stockholders sold 13.67 million shares of its common stock at an initial public offering price of $32 to raise about $437.3 million. &nbsp;Hinge Health was founded in 2014 by Daniel Perez and Gabriel Mecklenburg and is backed by venture capital firm Insight Partners. It announced its intent to go public in March.The firm made revenue of $123.8 million in the first quarter and net income of $17.1 million.A Stocktwits user opined that the stock might be “worth watching.”<stembedurl>https://stocktwits.com/ReWorkinvest/message/615490699</stembedurl>Connected TV advertising platform MNTN (MNTN), of which actor Ryan Reynolds is Chief Creative Director, also debuted on the NYSE on Thursday. Shares of the Austin-based company opened at $21, up 31% from its IPO price of $16.Blackrock-backed <a href="https://stocktwits.com/symbol/MNTN">MNTN</a> had reportedly put its IPO ambitions on hold in early April after President Donald Trump’s tariffs stirred up market turmoil.However, the recently announced 90-truce between China and the U.S, which resulted in significantly reduced tariffs on imports, has rekindled market confidence.Last week, Israeli multi-asset investment and social trading company eToro (<a href="https://stocktwits.com/symbol/ETOR">ETOR</a>) debuted on Nasdaq and opened at $69.69, up from its IPO price of $52.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/lightspeed-commerce-q4-2025-earnings/ch09kuhRbpy">Lightspeed Commerce Stock Slides As Impairment Charge Hits Earnings: But Retail’s Optimistic</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hinge Health, MNTN Shares Soar In NYSE Debut

Hinge Health was founded in 2014 by Daniel Perez and Gabriel Mecklenburg and is backed by venture capital firm Insight Partners.

Hinge Health IPO surges 23% on debut

Investing.com -- Today’s IPO for healthcare service  Hinge Health  Inc (NYSE:HNGE) opened for trading at $39.25 per share after pricing 13,666,000 shares of common stock at $32 per share, the top end of the expected $28-$32 range.

Hinge Health, Inc. is a digital healthcare company, which engages in software for joint and muscle health care. It leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for its clients. The firm has designed its platform to address a broad spectrum of MSK care, ranging from acute injury, to chronic pain, to post-surgical rehabilitation, and the platform can help to ease members’ pain, improve their function, and reduce their need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere. The company was founded by Daniel Perez and Gabriel Mecklenburg in 2014 and is headquartered in San Francisco, CA.

Hinge Health Inc. - Ordinary Shares - Class A

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

HNGE
Hinge Health, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HNGE News

HNGEHinge Health, Inc.